Screener
Ginkgo Bioworks DNA Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Other | 48 | 262 |
| Net cash provided by (used in) investing activities | 34,219 | (262,572) |
| Cash flows from financing activities: | ||
| Proceeds from ATM offering | 17,049 | — |
| Payment of issuance costs related to ATM offering | (560) | — |
| Principal payments on finance leases | (19) | (305) |
| Net cash provided by (used in) financing activities | 16,470 | (305) |
| Effect of foreign exchange rates on cash and cash equivalents | (86) | 260 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Ginkgo Bioworks's financing cash flow?
- Ginkgo Bioworks (DNA) reported financing cash flow of $16.49M in Q2 2026.
- How has Ginkgo Bioworks's financing cash flow changed year-over-year?
- Ginkgo Bioworks's financing cash flow increased by 16925.5% year-over-year, from -$98K to $16.49M.
- What is the long-term trend for Ginkgo Bioworks's financing cash flow?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's financing cash flow has grown at a -67.3% compound annual growth rate (CAGR), from $1.55B to $17.78M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Ginkgo Bioworks's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude